These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 28576211

  • 1. Morpho-functional analysis of Stargardt Disease for reading.
    Sasso P, Scupola A, Silvestri V, Amore FM, Abed E, Calandriello L, Grimaldi G, Caporossi A.
    Can J Ophthalmol; 2017 Jun; 52(3):287-294. PubMed ID: 28576211
    [Abstract] [Full Text] [Related]

  • 2. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB, Iacono P, Triolo G, La Spina C, Zucchiatti I, Cicinelli MV, Borrelli E, Manitto MP, Martina E, Bandello F.
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [Abstract] [Full Text] [Related]

  • 3. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T, Greenstein VC, Sodi A, Tsang SH, Burke TR, Passerini I, Allikmets R, Virgili G, Cavallini GM, Rizzo S.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [Abstract] [Full Text] [Related]

  • 4. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
    Ritter M, Zotter S, Schmidt WM, Bittner RE, Deak GG, Pircher M, Sacu S, Hitzenberger CK, Schmidt-Erfurth UM, Macula Study Group Vienna.
    Invest Ophthalmol Vis Sci; 2013 Sep 27; 54(9):6416-25. PubMed ID: 23882696
    [Abstract] [Full Text] [Related]

  • 5. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P, Testa F, Rossi S, Di Iorio V, Orrico A, Auricchio A, Simonelli F.
    Invest Ophthalmol Vis Sci; 2016 Jul 01; 57(9):OCT247-52. PubMed ID: 27409479
    [Abstract] [Full Text] [Related]

  • 6. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
    Abalem MF, Otte B, Andrews C, Joltikov KA, Branham K, Fahim AT, Schlegel D, Qian CX, Heckenlively JR, Jayasundera T.
    Am J Ophthalmol; 2017 Dec 01; 184():181-188. PubMed ID: 29038010
    [Abstract] [Full Text] [Related]

  • 7. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP, Progression of Stargardt Disease Study Group.
    Ophthalmology; 2016 Apr 01; 123(4):817-28. PubMed ID: 26786511
    [Abstract] [Full Text] [Related]

  • 8. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
    Cai CX, Light JG, Handa JT.
    Am J Ophthalmol; 2018 Feb 01; 186():1-9. PubMed ID: 29126757
    [Abstract] [Full Text] [Related]

  • 9. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN, ProgStar Study Group.
    JAMA Ophthalmol; 2017 Jul 01; 135(7):696-703. PubMed ID: 28542693
    [Abstract] [Full Text] [Related]

  • 10. Microperimetric assessment of the two optical coherence tomography subtypes of acute macular neuroretinopathy.
    Battaglia Parodi M, Iacono P, Panico D, Cascavilla M, Bandello F.
    Clin Exp Ophthalmol; 2015 Jul 01; 43(7):637-42. PubMed ID: 25752249
    [Abstract] [Full Text] [Related]

  • 11. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
    Testa F, Rossi S, Sodi A, Passerini I, Di Iorio V, Della Corte M, Banfi S, Surace EM, Menchini U, Auricchio A, Simonelli F.
    Invest Ophthalmol Vis Sci; 2012 Jul 03; 53(8):4409-15. PubMed ID: 22661472
    [Abstract] [Full Text] [Related]

  • 12. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
    Daich Varela M, Laich Y, Hashem SA, Mahroo OA, Webster AR, Michaelides M.
    Ophthalmology; 2023 Nov 03; 130(11):1182-1190. PubMed ID: 37331482
    [Abstract] [Full Text] [Related]

  • 13. The absence of fundus abnormalities in Stargardt disease.
    Bax NM, Lambertus S, Cremers FPM, Klevering BJ, Hoyng CB.
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun 03; 257(6):1147-1157. PubMed ID: 30903310
    [Abstract] [Full Text] [Related]

  • 14. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
    Burke TR, Rhee DW, Smith RT, Tsang SH, Allikmets R, Chang S, Lazow MA, Hood DC, Greenstein VC.
    Invest Ophthalmol Vis Sci; 2011 Oct 10; 52(11):8006-15. PubMed ID: 21873672
    [Abstract] [Full Text] [Related]

  • 15. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
    Querques L, Querques G, Forte R, Souied EH.
    Am J Ophthalmol; 2012 Jun 10; 153(6):1110-5. PubMed ID: 22321805
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
    Mustafic N, Ristoldo F, Nguyen V, Fraser CL, Invernizzi A, Jamieson RV, Grigg JR.
    Doc Ophthalmol; 2020 Dec 10; 141(3):205-215. PubMed ID: 32240425
    [Abstract] [Full Text] [Related]

  • 17. [Contribution of multimodal imaging in the various stages of Stargardt disease].
    El Matri L, Falfoul Y, Kortli M, Hassairi A, Charfi H, Turki A, Kort F, Chebil A.
    J Fr Ophtalmol; 2017 Oct 10; 40(8):666-675. PubMed ID: 28919188
    [Abstract] [Full Text] [Related]

  • 18. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
    Gomes NL, Greenstein VC, Carlson JN, Tsang SH, Smith RT, Carr RE, Hood DC, Chang S.
    Invest Ophthalmol Vis Sci; 2009 Aug 10; 50(8):3953-9. PubMed ID: 19324865
    [Abstract] [Full Text] [Related]

  • 19. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
    Pilotto E, Convento E, Guidolin F, Abalsamo CK, Longhin E, Parrozzani R, Midena E.
    JAMA Ophthalmol; 2016 Aug 01; 134(8):873-9. PubMed ID: 27253760
    [Abstract] [Full Text] [Related]

  • 20. Microperimetry, fundus autofluorescence, and retinal layer changes in progressing geographic atrophy.
    Pilotto E, Benetti E, Convento E, Guidolin F, Longhin E, Parrozzani R, Midena E.
    Can J Ophthalmol; 2013 Oct 01; 48(5):386-93. PubMed ID: 24093185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.